Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $46.64 +1.72%
EPS Growth %: -34.9%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -34.9%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 EPS of $13.54. Revenue for the quarter came in at $69.8 million.
For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- RBC Capital Reiterates Sector Perform Rating on Freehold Royalties Ltd. (FRU:CN) (FRHLF)
- OpenAI's Sam Altman to brief the UN Security Council next week - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
